Kestra Medical Technologies (KMTS) Accumulated Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Accumulated Expenses data on file, last reported at $23.0 million in Q2 2026.

• On a quarterly basis, Accumulated Expenses rose 4824.36% year-over-year to $23.0 million in Q2 2026; TTM through Apr 2026 was $23.0 million, a 4824.36% increase from a year earlier, with the FY2026 full-year figure at $23.0 million, up 4824.36% from the prior year.
• Accumulated Expenses for Q2 2026 stood at $23.0 million, up from $1.1 million in the prior quarter.
• Over the last five years, Accumulated Expenses for KMTS reached as high as $23.0 million in Q2 2026 and fell as low as $234000.0 in Q2 2024.
• Historically, Accumulated Expenses has averaged $5.9 million across 3 years, with a median of $1.1 million in 2026.
• On a YoY basis, Accumulated Expenses climbed as much as 4824.36% in 2026 and fell as far as 46.32% in 2026.
• Year by year, Accumulated Expenses stood at $234000.0 in 2024, then soared by 89.32% to $443000.0 in 2025, then jumped by 5102.26% to $23.0 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $23.0 million in Q2 2026, $1.1 million in Q1 2026, and $443000.0 in Q4 2025.